BOLDADVOCACY Division of BOLDSCIENCE Strengthens Leadership Team with Tori Fahrney
December 12, 2024 | BOLDSCIENCE, Medical Communications, Pharma, advocacy, agency, medcomms, medical affairs, patients, strategic communication
BOLDSCIENCE, One of the Fastest-Growing Firms in the Health Care Sector, and the Minds + Assembly Platform Reinforce Importance of Supporting Patients and Caregivers
NEW YORK, December 12, 2024 – BOLDSCIENCE, part of the Minds + Assembly platform, is pleased to announce that Tori Fahrney has joined the company as Executive Vice President of BOLDADVOCACY – their new specialty division dedicated to patient advocacy and engagement.
BOLDADVOCACY focuses on supporting pharmaceutical and biotech clients in their quest to improve the lives of patients by uniting science together with the patient voice into meaningful solutions for communities around the world. As biopharma implements patient-centered drug development and commercialization processes, they have a growing need for a science-focused, creative and digitally savvy medical communications agency that understands patients and knows how to incorporate their voice into action. With the addition of Tori Fahrney, BOLDADVOCACY has a champion who understands the challenges and opportunities that biopharma face.
Tori brings over 25 years of experience in building patient communities by creating strategic partnerships across industry and patient advocacy groups. “As a patient advocate and active caregiver, I have a passion for connecting patients with advocacy and industry to ultimately improve the lives of patients,” Fahrney stated. “When people and families are faced with challenging diagnoses, they seek to connect with others like them to gather and share experiences, exchange knowledge, and advocate for their collective needs. I work with clients to gather these important insights that can help guide business decisions so that together we can deliver the greatest impact to patients and their caregivers.”
Building from the strength of BOLDSCIENCE’s scientific expertise, BOLDADVOCACY is uniquely positioned to drive patient-centered engagement across the product lifecycle – including product strategy, patient journey mapping, clinical trial planning, and tactical execution around launch and beyond. Tori is an expert in health literacy and behavior modification principles. She has helped shepherd many product launches throughout her career and developed or enhanced more than 20 patient support programs to ensure timely access to medications. These programs also ensure patients and caregivers receive the much-needed emotional support that comes along with living with any serious chronic condition.
With Tori at the helm, patient advocacy now occupies an elevated strategic role across BOLDSCIENCE and the Minds + Assembly platform and serves as a shared-service function from R&D to late-stage commercialization.
Mark Lydiatt, Minds + Assembly Chief Executive Officer, adds “Tori is a seasoned leader who brings significant experience in building patient advocacy offerings for biopharma clients. With the emphasis on building more patient-centric organizations, Tori knows how to work with clients to embed patient insights from the earliest stages of product development through to real-world use. Through planned and optimized collaborations, our ultimate aim is to improve drug development with patients; not just for patients.”
For further information, please visit www.boldsci.com, or contact us at advocacy@boldsci.com.
This content was provided by BOLDSCIENCE
Company Details
Latest Content from BOLDSCIENCE
Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions
New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...
BOLDADVOCACY Division of BOLDSCIENCE Strengthens Leadership Team with Tori Fahrney
BOLDSCIENCE, One of the Fastest-Growing Firms in the Health Care Sector, and the Minds + Assembly Platform Reinforce Importance of Supporting Patients and Caregivers
BOLDSCIENCE launches BOLDAPPROVALS division
BOLDAPPROVALS, a new division of the medical communications agency BOLDSCIENCE, will help pharmaceutical and biotech clients gain regulatory approval with comprehensive services that include preparation for US Food and Drug...
BOLDSCIENCE welcomes Steven Cohen to its leadership team to expand its strategic communication consulting services into regulatory approvals
Medical communications agency BOLDSCIENCE has hired industry veteran Steven Cohen to lead a new division that will help pharmaceutical and biotech clients navigate the most critical challenges they face throughout...
BOLDSCIENCE marks its 1-year launch anniversary with record growth
Specialist medical communication agency BOLDSCIENCE has seen demand for its ‘scientifically creative’ service offerings soar over the past year as global pharma and biotech clients search for trusted partners with...
New medical communications agency BOLDSCIENCE launches
The new global agency boldly sets out its plans to become a major player in med comms